Novo Nordisk CEO explains Levemir discontinuation
The highest of government of Novo Nordisk informed a Senate panel Tuesday it was a “tough alternative” to discontinue the long-acting insulin Levemir however he had to take action due to market forces. The Danish drugmaker beforehand introduced it could cease gross sales of Levemir vials by the top of December. Novo Nordisk’s determination has
Read More